Publications of C. Anish
All genres
Journal Article (24)
2013
Journal Article
52 (36), pp. 9524 - 9528 (2013)
Plague detection by anti-carbohydrate antibodies. Angewandte Chemie International Edition
Journal Article
8 (11), pp. 2412 - 2422 (2013)
Immunogenicity and diagnostic potential of synthetic antigenic cell surface glycans of Leishmania. ACS Chemical Biology
Journal Article
49 (64), pp. 7159 - 7161 (2013)
Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine. Chemical Communications
Journal Article
135 (26), pp. 9713 - 9722 (2013)
Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope. Journal of the American Chemical Society Book Chapter (2)
2015
Book Chapter
Lepenies, B.). Springer Science+Business Media, New York (2015)
Generation of monoclonal antibodies against defined oligosaccharide antigens. In: Carbohydrate-Based Vaccines, pp. 57 - 80 (Ed. 2013
Book Chapter
Carbohydrate Vaccines. In: Biotherapeutics: Recent Development using Chemical and Molecular Biology, pp. 68 - 104 (Eds. Jones, L. H.; McKnight, A. J.). RSC, Cambridge (2013)
Meeting Abstract (3)
2016
Meeting Abstract
70 (S 01), P489. 57. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., Leipzig, March 02, 2016 - March 05, 2016. (2016)
Passive Immunisierung mit dem monoklonalen Antikörper 1H8 schützt Mäuse vor pneumogener Sepsis. In Pneumologie, 2014
Meeting Abstract
24 (11), p. 1129 - 1129. Joint Meeting of the Society-for-Glycobiology (SFG) and the
Japanese-Society-of-Carbohydrate-Research (JSCR), Honolulu, HI, November 16, 2014 - November 19, 2014. Oxford University Press, Oxford (2014)
Deciphering glycan-antibody interactions: towards a carbohydrate-based vaccine against Clostridium difficile. In Glycobiology,
Meeting Abstract
24 (11), p. 1122 - 1122. Joint Meeting of the Society-for-Glycobiology (SFG) and the
Japanese-Society-of-Carbohydrate-Research (JSCR), Honolulu, HI, November 16, 2014 - November 19, 2014. Oxford University Press, Oxford (2014)
Antigenic potential of a highly conserved lipopolysaccharide inner core structure defined by synthetic approach. In Glycobiology, Patent (11)
2017
Patent
Synthetic vaccines against Streptococcus pneumoniae serotype 2. (2017)
2016
Patent
Vaccines against Streptococcus pneumoniae serotype 5. WO2016198170 (2016)
Patent
Antibodies for prevention and treatment of diseases caused by Clostridium difficile. (2016)
Patent
Vaccines against Streptococcus pneumoniae serotype 4. EP3230297 (2016)
Patent
Synthetic vaccines against Streptococcus pneumoniae serotype 8. (2016)
Patent
Vaccine against carbapenem-resistant klebsiella pneumoniae. EP3274358 (2016)
2015
Patent
Synthetic vaccines against Streptococcus pneumoniae type 1. (2015)
2014
Patent
Total synthesis and immunological evaluation of saccharide moieties of the lipopolysaccharide from neisseria meningitidis. EP2766024 A1 (2014)
2013
Patent
Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools. EP2739636 (2013)
Patent
Total synthesis of the core tetrasaccharide of the lipopolysaccharide from Neisseria meningitidis. (2013)
2012
Patent
Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3. WO2015040140 (2012)